Prevention and treatment of urinary tract infection with probiotics: Review and research perspective

D Borchert; L Sheridan; A Papatsoris; Z Faruquz; JM Barua; I Junaid; Y Pati; F Chinegwundoh; N Buchholz

doi:10.4103/0970-1591.40604

Users online:1657

Home

Current Issue

Ahead of print

Editorial Board

Archives

Symposia

Guidelines

Subscriptions

REVIEW ARTICLE

Year : 2008 | Volume : 24 | Issue : 2 | Page : 139-144

Prevention and treatment of urinary tract infection with probiotics: Review and research perspective

D Borchert¹, L Sheridan², A Papatsoris¹, Z Faruquz¹, JM Barua³, I Junaid¹, Y Pati⁴, F Chinegwundoh⁵, N Buchholz⁵
¹ Department of Urology, St. Bartholomew's Hospital, London, United Kingdom
² Department of Microbiology, St. Bartholomew's Hospital, London, United Kingdom
³ Department of Urology, Barking, Havering and Redbridge Hospitals, London, United Kingdom
⁴ Department of Urology, St. Bartholomew's Hospital; Department of Urology, Homerton University Hospitals, London, United Kingdom
⁵ Department of Urology, St. Bartholomew's Hospital; Department of Urology, Newham University Hospitals, London, United Kingdom

Correspondence Address:
D Borchert
Ground Floor, KGV Block, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE
United Kingdom

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/0970-1591.40604

The spiralling costs of antibiotic therapy, the appearance of multiresistant bacteria and more importantly for patients and clinicians, unsatisfactory therapeutic options in recurrent urinary tract infection (RUTI) calls for alternative and advanced medical solutions. So far no sufficient means to successfully prevent painful and disabling RUTI has been found. Even though long-term oral antibiotic treatment has been used with some success as a therapeutic option, this is no longer secure due to the development of bacterial resistance. One promising alternative is the use of live microorganisms (probiotics) to prevent and treat recurrent complicated and uncomplicated urinary tract infection (UTI). The human normal bacterial flora is increasingly recognised as an important defence to infection. Since the advent of antibiotic treatment five decades ago, a linear relation between antibiotic use and reduction in pathogenic bacteria has become established as medical conventional wisdom. But with the use of antibiotics the beneficial bacterial flora hosted by the human body is destroyed and pathogenic bacteria are selectively enabled to overgrow internal and external surfaces. The benign bacterial flora is crucial for body function and oervgrowth with pathogenic microorganisms leads to illness. Thus the concept of supporting the human body's normal flora with live microorganisms conferring a beneficial health effect is an important medical strategy.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	25914

Printed	453

Emailed	8

PDF Downloaded	1305

Comments	[Add]

Cited by others	19